Delai Chen

Director, Nanoparticle Formulation Beam Therapeutics

Seminars

Wednesday 29th July 2026
Exploring LNP Delivery Approaches for Next-Generation Base Editing
2:00 pm
  • Examining early-stage-stage LNP design choices for base editing, enabling smoother progression from discovery toward development
  • Comparing delivery needs of base editors versus nucleases, supporting smarter modality decisions
  • Outlining emerging targeting and biodistribution requirements, strengthening future in vivo editing strategies
Delai Chen of Beam Therapeutics - 5th In Vivo Cell Engineering & Gene Editing Summit